| POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
POLR2L |
POLR2L: DNA-directed RNA polymerases I, II, and III subunit RPABC5 |
56.670 |
Evidence |
|
| BCL2L1 |
BCL2L1, BCL2L, BCLX: Apoptosis regulator Bcl-X |
BMF |
BMF: Bcl-2-modifying factor |
56.200 |
Evidence |
|
| TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
MMP3 |
MMP3, STMY1: Stromelysin-1 precursor |
54.310 |
Evidence |
O
|
| CHMP6 |
CHMP6, VPS20: Charged multivesicular body protein 6 |
VPS25 |
VPS25, DERP9, EAP20: Vacuolar protein-sorting-associated protein 25 |
54.050 |
Evidence |
|
| SNF8 |
SNF8, EAP30: Vacuolar-sorting protein SNF8 |
VPS25 |
VPS25, DERP9, EAP20: Vacuolar protein-sorting-associated protein 25 |
54.050 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
52.880 |
Evidence |
O
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
CSK |
CSK: Tyrosine-protein kinase CSK |
52.550 |
Evidence |
O
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
51.550 |
Evidence |
O
|
| ABCD1 |
ABCD1, ALD: ATP-binding cassette sub-family D member 1 |
ABCD2 |
ABCD2, ALD1, ALDL1, ALDR, ALDRP: ATP-binding cassette sub-family D member 2 |
50.000 |
Evidence |
O
|
| POLR2C |
POLR2C, A-152E5.7: DNA-directed RNA polymerase II subunit RPB3 |
POLR2E |
POLR2E: DNA-directed RNA polymerases I, II, and III subunit RPABC1 |
49.0 |
Evidence |
O
|
| EFNA3 |
EFNA3, EFL2, EPLG3, LERK3: Ephrin-A3 precursor |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
47.650 |
Evidence |
O
|
| INSR |
INSR: Insulin receptor precursor |
CSK |
CSK: Tyrosine-protein kinase CSK |
47.370 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
45.990 |
Evidence |
O
|
| GTF2A1 |
GTF2A1, TF2A1: Transcription initiation factor IIA subunit 1 |
GTF2A2 |
GTF2A2, TF2A2: Transcription initiation factor IIA gamma chain |
45.230 |
Evidence |
O
|
| ABCD3 |
ABCD3, PMP70, PXMP1: ATP-binding cassette sub-family D member 3 |
PEX19 |
PEX19, HK33, OK/SW-cl.22, PXF: Peroxisomal biogenesis factor 19 |
43.830 |
Evidence |
|
| CCNF |
CCNF: G2/mitotic-specific cyclin-F |
CCNB1 |
Cyclin B1 |
40.730 |
Evidence |
O
|
| ABCD3 |
ABCD3, PMP70, PXMP1: ATP-binding cassette sub-family D member 3 |
ABCD2 |
ABCD2, ALD1, ALDL1, ALDR, ALDRP: ATP-binding cassette sub-family D member 2 |
40.500 |
Evidence |
O
|
| ARPC1B |
ARC41, ARPC1B: Actin-related protein 2/3 complex subunit 1B |
ACTG1 |
ACTR2, ARP2: Actin-related protein 2 |
39.490 |
Evidence |
O
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
EFNA4 |
EFNA4, EPLG4, LERK4: Ephrin-A4 precursor |
39.010 |
Evidence |
|
| BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
38.160 |
Evidence |
O
|
| HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
37.330 |
Evidence |
O
|
| POLR2C |
POLR2C, A-152E5.7: DNA-directed RNA polymerase II subunit RPB3 |
POLR2L |
POLR2L: DNA-directed RNA polymerases I, II, and III subunit RPABC5 |
37.190 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
36.670 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
ATR |
ATR, FRP1: Serine/threonine-protein kinase ATR |
36.660 |
Evidence |
|
| IRF3 |
IRF3: Interferon regulatory factor 3 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
36.660 |
Evidence |
O
|
-